Stay updated on Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial

Sign up to get notified when there's something new on the Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2026-02-11T11:30:08.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and NIH operations status, with guidance to check opm.gov for updates. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:15:21.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Show glossary feature added and QC metadata labels updated, including a revision/version tag. Core trial data and eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T05:48:58.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4; no user-facing content changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:27:43.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with Missouri as a location. Removed the Missouri Locations label and updated the page revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T22:41:09.000Z thumbnail image
  6. Check
    81 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.3.2 where Revision: v3.2.0 was previously listed, with no changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:32:45.000Z thumbnail image

Stay in the know with updates to Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial page.